K2 Principal Fund’s Eli Lilly LLY Stock Holding History

K2 Principal Fund’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-20,000	Closed	-$1.47M	–	333
2016 Q4	$1.47M	Buy	+20,000	New	+$1.49M	0.14%	140

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

K2 Principal Fund's LLY Position: Q1 2017 in Review

K2 Principal Fund sold out of Eli Lilly (LLY) in Q1 2017, closing a stake of 20,000 shares — an estimated $1.47M sold.

K2 Principal Fund first reported a position in LLY in Q4 2016 and held it in 1 quarter. The position peaked at $1.47M in Q4 2016. 1,249 funds tracked by Wall St. Rank hold LLY as of Q1 2017.

K2 Principal Fund reported no remaining Eli Lilly position as of Q1 2017 after selling out during the quarter.
K2 Principal Fund sold 20,000 Eli Lilly shares in Q1 2017, an estimated $1.47M.
K2 Principal Fund first reported a position in Eli Lilly in Q4 2016 and held it in 1 quarter.
K2 Principal Fund's Eli Lilly position peaked at $1.47M in Q4 2016.
1,249 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2017.

Based on K2 Principal Fund's 13F filing for Q1 2017, filed 11 May 2017.